Literature DB >> 19647948

Focal adhesion kinase (FAK) expression in normal and neoplastic lymphoid tissues.

Sermin Ozkal1, Jennifer C Paterson, Sara Tedoldi, Martin-Leo Hansmann, Aydanur Kargi, Sanjiv Manek, David Y Mason, Teresa Marafioti.   

Abstract

Focal adhesion kinase (FAK) is a protein tyrosine kinase essential for intracellular regulatory events, such as cell growth, differentiation, migration and tumor metastasis. The aim of this study was to analyze the expression of FAK protein in a series of normal and neoplastic lymphoid tissues. An anti-FAK antibody was used to study the protein expression in paraffin-embedded samples of normal and neoplastic, hematolymphoid and non-hematolymphoid tissues by immunohistochemistry. In normal hematolymphoid tissue, the strongest expression of FAK was detected in germinal center and marginal-zone B cells; positive staining was also found in mantle zone B cells. In human lymphomas, FAK was expressed mostly in B-cell lymphomas and was predominantly negative in T-cell lymphoma. In Hodgkin lymphomas, FAK was found only in the neoplastic cells of lymphocyte predominant type, whereas the tumor cells of the classical form were FAK-negative. We demonstrate for the first time the expression of FAK in paraffin-embedded hematolymphoid tissue samples. Its differential expression in lymphomas may be of relevance for some B-cell neoplasms by using it as an additional marker to distinguish B- from T-lymphoblastic leukemia/lymphoma to further differentiate lymphocyte predominant from classical Hodgkin lymphoma.

Entities:  

Mesh:

Substances:

Year:  2009        PMID: 19647948     DOI: 10.1016/j.prp.2009.07.002

Source DB:  PubMed          Journal:  Pathol Res Pract        ISSN: 0344-0338            Impact factor:   3.250


  9 in total

1.  A study of the focal adhesion kinase inhibitor GSK2256098 in patients with recurrent glioblastoma with evaluation of tumor penetration of [11C]GSK2256098.

Authors:  Nicholas F Brown; Matthew Williams; Hendrik-Tobias Arkenau; Ronald A Fleming; Jerry Tolson; Li Yan; Jianping Zhang; Rajendra Singh; Kurt R Auger; Laurie Lenox; David Cox; Yvonne Lewis; Christophe Plisson; Graham Searle; Azeem Saleem; Sarah Blagden; Paul Mulholland
Journal:  Neuro Oncol       Date:  2018-11-12       Impact factor: 12.300

2.  FAK-heterozygous mice display enhanced tumour angiogenesis.

Authors:  Vassiliki Kostourou; Tanguy Lechertier; Louise E Reynolds; Delphine M Lees; Marianne Baker; Dylan T Jones; Bernardo Tavora; Antoine R Ramjaun; Graeme M Birdsey; Stephen D Robinson; Maddy Parsons; Anna M Randi; Ian R Hart; Kairbaan Hodivala-Dilke
Journal:  Nat Commun       Date:  2013       Impact factor: 14.919

3.  Identification of interconnected markers for T-cell acute lymphoblastic leukemia.

Authors:  Emine Guven Maiorov; Ozlem Keskin; Ozden Hatirnaz Ng; Ugur Ozbek; Attila Gursoy
Journal:  Biomed Res Int       Date:  2013-07-15       Impact factor: 3.411

4.  Integrin VLA-5 and FAK are Good Targets to Improve Treatment Response in the Philadelphia Chromosome Positive Acute Lymphoblastic Leukemia.

Authors:  Zhongbo Hu; William B Slayton
Journal:  Front Oncol       Date:  2014-05-15       Impact factor: 6.244

5.  Niacin Suppresses Progression of Atherosclerosis by Inhibiting Vascular Inflammation and Apoptosis of Vascular Smooth Muscle Cells.

Authors:  Gang Su; Guangli Sun; Hai Liu; Liliang Shu; Jingchao Zhang; Longhui Guo; Chen Huang; Jing Xu
Journal:  Med Sci Monit       Date:  2015-12-29

Review 6.  Role of Non Receptor Tyrosine Kinases in Hematological Malignances and its Targeting by Natural Products.

Authors:  Kodappully S Siveen; Kirti S Prabhu; Iman W Achkar; Shilpa Kuttikrishnan; Sunitha Shyam; Abdul Q Khan; Maysaloun Merhi; Said Dermime; Shahab Uddin
Journal:  Mol Cancer       Date:  2018-02-19       Impact factor: 27.401

Review 7.  Cell Adhesion and Matrix Stiffness: Coordinating Cancer Cell Invasion and Metastasis.

Authors:  Vasiliki Gkretsi; Triantafyllos Stylianopoulos
Journal:  Front Oncol       Date:  2018-05-04       Impact factor: 6.244

8.  Selective Killing of Melanoma Cells With Non-Thermal Atmospheric Pressure Plasma and p-FAK Antibody Conjugated Gold Nanoparticles.

Authors:  Byul Bo Ra Choi; Jeong Hae Choi; Jin Woo Hong; Ki Won Song; Hae June Lee; Uk Kyu Kim; Gyoo Cheon Kim
Journal:  Int J Med Sci       Date:  2017-09-04       Impact factor: 3.738

9.  Inhibition of focal adhesion kinase overcomes resistance of mantle cell lymphoma to ibrutinib in the bone marrow microenvironment.

Authors:  Martina Rudelius; Mathias Tillmann Rosenfeldt; Ellen Leich; Hilka Rauert-Wunderlich; Antonio Giovanni Solimando; Andreas Beilhack; German Ott; Andreas Rosenwald
Journal:  Haematologica       Date:  2017-10-27       Impact factor: 9.941

  9 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.